Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epothilone D and Herceptin in HER-2 Positive Breast Cancer
NCT00337649Phase 2Completed
- Sponsor
- Roche
- Start
- May 2004
- Primary completion
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Epothilone D in breast cancer, sponsored by Roche. Started May 2004; status: completed.
02
Drugs
Epothilone D
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00337649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00337649.